Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CSBR

Champions Oncology (CSBR)

Champions Oncology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR
DataHoraFonteTítuloCódigoCompanhia
15/10/201507:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CSBRChampions Oncology Inc
14/10/201507:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CSBRChampions Oncology Inc
25/09/201515:41Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CSBRChampions Oncology Inc
11/09/201517:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CSBRChampions Oncology Inc
10/09/201517:05PR Newswire (US)Champions Oncology Reports Results for the First Quarter Ended July 31, 2015NASDAQ:CSBRChampions Oncology Inc
10/09/201517:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CSBRChampions Oncology Inc
08/09/201511:30PR Newswire (US)Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2015NASDAQ:CSBRChampions Oncology Inc
01/09/201518:10Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:CSBRChampions Oncology Inc
31/08/201514:54Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CSBRChampions Oncology Inc
21/08/201510:38PR Newswire (US)Champions Oncology Announces Uplisting to NASDAQNASDAQ:CSBRChampions Oncology Inc
15/12/200920:00PR Newswire (US)Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial ResultsNASDAQ:CSBR
18/11/200911:00PR Newswire (US)Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the RepurposingNASDAQ:CSBR
12/11/200911:52PR Newswire (US)Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to GuNASDAQ:CSBR
27/10/200910:00PR Newswire (US)Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment ofNASDAQ:CSBR
26/10/200910:52PR Newswire (US)Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)NASDAQ:CSBR
13/10/200909:52PR Newswire (US)U.S. Patent Issued for Champions Biotechnology's Lead Oncology DrugNASDAQ:CSBR
14/09/200921:44PR Newswire (US)Champions Biotechnology Reports Fiscal 2010 First Quarter Financial ResultsNASDAQ:CSBR
10/09/200909:23PR Newswire (US)Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration AgreementNASDAQ:CSBR
09/09/200911:11PR Newswire (US)Champions Biotechnology to Present at Rodman & Renshaw's Eleventh Annual Healthcare ConferenceNASDAQ:CSBR
01/09/200909:55PR Newswire (US)Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech LeaderNASDAQ:CSBR
27/08/200917:26PR Newswire (US)Champions Biotechnology Reports Fiscal 2009 Full-Year Financial ResultsNASDAQ:CSBR
16/07/200909:22PR Newswire (US)Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) TeNASDAQ:CSBR
01/06/200909:52PR Newswire (US)Champions Biotechnology, Inc. Launches PersonalizedCancerTreatment.comNASDAQ:CSBR
08/04/200909:22PR Newswire (US)Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology BusinessNASDAQ:CSBR
18/03/200909:22PR Newswire (US)Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial ResultsNASDAQ:CSBR
05/02/200911:22PR Newswire (US)Champions Biotechnology, Inc.'s Doug Burkett, PhD, to Present at BIO CEO & Investor ConferenceNASDAQ:CSBR
30/07/200809:30PR Newswire (US)Champions Biotechnology Reports Fiscal 2008 Full-Year Financial ResultsNASDAQ:CSBR
17/06/200809:00PR Newswire (US)Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug CandidateNASDAQ:CSBR
07/05/200809:30PR Newswire (US)Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology DrugsNASDAQ:CSBR
06/05/200809:30PR Newswire (US)Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology DrNASDAQ:CSBR
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR